Oxytocin-Related Trial NCT04373902 on Cord Clamping Completed

A clinical trial listing update was recorded on September 25, 2026, for the study titled "Physiological-based Cord Clamping in Congenital Diaphragmatic Hernia," registered as NCT04373902. The trial status is listed as completed. The phase is listed as not applicable. This study involves oxytocin, a compound with approved regulatory status, in the context of delivery room management for infants with congenital diaphragmatic hernia. No results or outcome data are included in this update. The listing reflects only the change in trial status to completed as of the date noted. No efficacy, safety, or comparative findings are described in the available record. Readers should note that a completed status indicates the study has concluded data collection or study procedures, not that results have been published or reviewed. Further details on trial design, endpoints, or findings would require review of the full study record or subsequent publications, if any are released. This brief reports only the status change as recorded in the trial registry entry. For more background on oxytocin, including its approved uses and general profile, readers can consult the compound overview.